Inventor · disambiguated record
Samuel David
Also filed as: DAVID SAMUEL · THIES PETER W
25 granted patents·3 pending applications·108 citations·filing 1977–2017
95Inventor score
Top patents by PatentIndex Score
28 records- 0182US7241770B2Hydronopol derivatives as agonists on human ORL1 receptorsSOLVAY PHARM GMBH·Filed 2004·Granted Jul 10, 2007·23 cites·7 claims
- 0282US7238470B2Method of treating or inhibiting obesitySOLVAY PHARM GMBH·Filed 2004·Granted Jul 3, 2007·9 cites·3 claims
- 0378US11583511B2Maresins for use in the treatment of CNS injuriesUNIV BARCELONA AUTONOMA·Filed 2017·Granted Feb 21, 2023·1 cites·17 claims
- 0475US4391819A2,9-Dioxa tricyclo [4,3,1,03,7 ] decane compounds and process of making sameKALI CHEMIE PHARMA GMBH·Filed 1981·Granted Jul 5, 1983·9 cites·11 claims
- 0574US6946243B2Method of identifying compounds suitable for treatment and/or prophylaxis of obesitySOLVAY PHARM GMBH·Filed 2001·Granted Sep 20, 2005·4 cites·15 claims
- 0671US5294638APhenyalkylaminoalkyl compounds and pharmaceutical compositions containing themKALI CHEMIE PHARMA GMBH·Filed 1993·Granted Mar 15, 1994·13 cites·16 claims
- 0768US7851630B2Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptorsSOLVAY PHARM BV·Filed 2004·Granted Dec 14, 2010·4 cites·6 claims
- 0864US6770649B21-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2002·Granted Aug 3, 2004·2 cites·12 claims
- 0963US8642658B2Treatment of neural diseases or conditionsRADZIOCH DANUTA·Filed 2009·Granted Feb 4, 2014·0 cites·14 claims
- 1063US7282325B2Method of preparing pharmaceutical compositionsSOLVAY PHARM GMBH·Filed 2004·Granted Oct 16, 2007·0 cites·2 claims
- 1161US9050294B2Treatment of neural diseases or conditionsUNIV MCGILL·Filed 2013·Granted Jun 9, 2015·0 cites·13 claims
- 1260US4182889AProcess for preparing 10-methyl-2,9-dioxatricyclo[4,3,1,03,7 ] decanesKALI CHEMIE PHARMA GMBH·Filed 1977·Granted Jan 8, 1980·4 cites·17 claims
- 1357US5438068AMethod of treating colon disturbances with pharmaceutical compositions containing imidazol-1-yl compoundsKALI CHEMIE PHARMA GMBH·Filed 1993·Granted Aug 1, 1995·12 cites·11 claims
- 1457US4158061A2,9-Dioxatricyclo[4,3,1,03,7 ] decane derivatives, processes for their preparation and pharmaceutical compositions thereofKALI CHEMIE PHARMA GMBH·Filed 1978·Granted Jun 12, 1979·3 cites·4 claims
- 1552US8759392B2Amides as inhibitors of human secreted phospholipase A2DENNIS EDWARD A·Filed 2009·Granted Jun 24, 2014·0 cites·6 claims
- 1652US6001833AUrea derivativesSOLVAY PHARM GMBH·Filed 1998·Granted Dec 14, 1999·10 cites·5 claims
- 1751US4117148A2,9-Dioxatricyclo [4,3,1,0,3,7] decane derivatives, processes for their preparation and pharmaceutical compositions thereofKALI CHEMIE PHARMA GMBH·Filed 1977·Granted Sep 26, 1978·2 cites·38 claims
- 1849US8420852B2Phospholipase A2 inhibitors and their use in treating neurological injury and diseaseDENNIS EDWARD A·Filed 2008·Granted Apr 16, 2013·0 cites·11 claims
- 1947US4980487ANovel valepotriate hydrin containing medicinesKALI CHEMIE PHARMA GMBH·Filed 1989·Granted Dec 25, 1990·4 cites·7 claims
- 2045US4141988A2,9-Dioxatricyclo[4,3,1,03,7 ]decane derivatives, processes for their preparation and pharmaceutical compositions thereofKALI CHEMIE PHARMA GMBH·Filed 1978·Granted Feb 27, 1979·3 cites·25 claims
- 2143US2006058225A1Used of inhibitors of phospholipase a2 for the treatment, prevention or diagnosis of neural inflammatory or demyelinating diseaseUNIV MCGILL·Filed 2003·Application pending·0 cites
- 2240US4207331A2,9-Dioxatricyclo[4,3,1,03,7 ]decane derivatives and pharmaceutical compositions thereofKALI CHEMIE PHARMA GMBH·Filed 1978·Granted Jun 10, 1980·1 cites·10 claims
- 2337US5212173AAlkylaminoalkylamine and ether compounds, processes and intermediates for their preparation, and medicaments containing themKALI CHEMIE PHARMA GMBH·Filed 1991·Granted May 18, 1993·4 cites·7 claims
- 2435US2010048727A1Perfluoroketone compounds and uses thereofDAVID SAMUEL·Filed 2008·Application pending·0 cites
- 2530US2003225011A1Phospholipase A2 expression and activity and use thereof for diagnosis, prognostication, prevention and treatment of neural inflammatory and demyelinating diseaseFiled 2002·Application pending·0 cites
- 2629US6040303A7-phenyl-1, 4-diazepane compounds, process for their preparation, and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 1998·Granted Mar 21, 2000·0 cites·6 claims
- 2729US4714709AN-(2,10-dioxa-tricyclo-[5,3,1,03,8 ]-undecane-5-yl)-tryptamine derivatives and medical compositions thereofKALI CHEMIE PHARMA GMBH·Filed 1984·Granted Dec 22, 1987·0 cites·16 claims
- 2826US4891384AValepotriate hydrin containing medicines used to treat uclers and motility disturbancesKALI CHEMIE PHARMA GMBH·Filed 1988·Granted Jan 2, 1990·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Samuel David files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →